Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Eiznhamer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|April 2, 2004
Betulinic acid: a promising anticancer candidateDavid A Eiznhamer, Ze-Qi Xu
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-onesAli Koohang, Nathan D Majewski, Erika L Szotek, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoidsAye Aye Mar, Erika L Szotek, Ali Koohang, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal modelsDavid A Eiznhamer, Michael T Flavin, Gary J Jesmok, et al.
HIV Clinical Trials|December 26, 2002
Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteersDavid A Eiznhamer, Terri Creagh, Jon L Ruckle, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studiesMarci L English, Christine E Fredericks, Nancy A Milanesio, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|April 2, 2004
Betulinic acid: a promising anticancer candidateDavid A Eiznhamer, Ze-Qi Xu
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-onesAli Koohang, Nathan D Majewski, Erika L Szotek, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoidsAye Aye Mar, Erika L Szotek, Ali Koohang, et al.
Pulmonary Pharmacology & Therapeutics|May 5, 2004
Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal modelsDavid A Eiznhamer, Michael T Flavin, Gary J Jesmok, et al.
HIV Clinical Trials|December 26, 2002
Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteersDavid A Eiznhamer, Terri Creagh, Jon L Ruckle, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studiesMarci L English, Christine E Fredericks, Nancy A Milanesio, et al.
Pageof 1